Cargando…
Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
RATIONALE: The sterilizing activity of the regimen used to treat multidrug resistant tuberculosis (MDR TB) has not been studied in a mouse model. OBJECTIVE AND METHODS: Swiss mice were intravenously inoculated with 6 log10 of Mycobacterium tuberculosis (TB) strain H37Rv, treated with second-line dru...
Autores principales: | Veziris, Nicolas, Ibrahim, Murad, Lounis, Nacer, Andries, Koen, Jarlier, Vincent |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048299/ https://www.ncbi.nlm.nih.gov/pubmed/21408613 http://dx.doi.org/10.1371/journal.pone.0017556 |
Ejemplares similares
-
Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase
por: Haagsma, Anna C., et al.
Publicado: (2011) -
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
por: Chauffour, Aurélie, et al.
Publicado: (2020) -
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice
por: Chauffour, Aurélie, et al.
Publicado: (2016) -
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
por: Fox, Gregory J., et al.
Publicado: (2013) -
Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
por: Wallis, Robert S., et al.
Publicado: (2012)